| Literature DB >> 19705649 |
G Ricci1, A Conti, M Paternoster, P Buccelli.
Abstract
The blood contained in the umbilical cord offers a precious source of pluripotent stem cells, easily obtainable without invasive procedures, a source that, unlike embryonic stem cells, affords greater respect for ethical concerns. In relation to the therapeutic potential of these stem cells, personalized blood banks for newborns have been created and in various countries systems of research and cryoconservation of umbilical cord blood have been created, especially in private facilities. This facilitates promotion of the culture of donation and development of a network of umbilical cord blood sources, and spurs research to evaluate the real therapeutic potential of these cells. Italy has long prohibited management of umbilical cord blood in private form. Today, with new laws, Italy has achieved the indispensable legislative update in acknowledgment of social needs. Actually, the achieved system is solid autologous conservation. It guarantees to conserve a greater number of umbilical cords in public and private facilities.Mesh:
Year: 2009 PMID: 19705649
Source DB: PubMed Journal: Med Law ISSN: 0723-1393